Investment
Features
FeesSafety
Academy
More
Pluang+

CCP-linked campaigns delayed $23.6B in US AI projects, says Bitcoin Policy Institute on Capitol Hill

Market News
29 Jul 2026
Crypto Briefing
View Source
Neutral
pluang ai news

The Bitcoin Policy Institute revealed that Chinese Communist Party-linked influence operations have blocked or delayed $23.6 billion in US AI infrastructure projects across 14 states. Their research highlights 21 campaigns involving moratoria and bans on data center construction, driven by CCP-affiliated media and a nonprofit network funded by Neville Roy Singham. This matters because AI data centers and Bitcoin mining share infrastructure needs, so regulatory battles affect both sectors. Lawmakers are now pushing for deeper investigations into these foreign influence networks.

More News

Raymond James raises Flex price target to $170 after strong Q1 earnings and AI-focused spin-off plan.

Raymond James raises Flex price target to $170 after strong Q1 earnings and AI-focused spin-off plan.

Raymond James upgraded Flex's price target from $150 to $170 following the company's strong fiscal Q1 2027 results, which included $7.93 billion in revenue and $1.00 adjusted earnings per share, beating estimates. Flex's Cloud and Power Infrastructur...

Analyst Insights
Bullish
37 minutes ago
Airbus reports strong earnings and revenue growth, boosting aerospace sector confidence.

Airbus reports strong earnings and revenue growth, boosting aerospace sector confidence.

Airbus exceeded expectations with earnings per share of $0.59 and revenue of $23.36 billion, driven by a 54% rise in adjusted EBIT and increased aircraft deliveries. The company successfully converted its large order backlog into earnings, with a 15%...

Company Fundamentals
Bullish
46 minutes ago
Sanofi halts amlitelimab trials, preps Q2 2026 earnings amid AI drug discovery push

Sanofi halts amlitelimab trials, preps Q2 2026 earnings amid AI drug discovery push

Sanofi is set to report its Q2 2026 earnings with expected EPS of $1.10 and revenue of $12.41 billion. The company halted clinical development of amlitelimab for atopic dermatitis, reflecting a strategic shift in its drug pipeline. Leadership changes...

Company Fundamentals
Neutral
52 minutes ago
Wingstop shows strong capital efficiency with ROIC more than double its cost of capital.

Wingstop shows strong capital efficiency with ROIC more than double its cost of capital.

Wingstop Inc. demonstrates strong financial health with a Return on Invested Capital (ROIC) of 25.05%, which is more than double its Weighted Average Cost of Capital (WACC) of 10.36%, resulting in a ROIC to WACC ratio of 2.42. This indicates Wingstop...

Market News
Bullish
52 minutes ago
Avery Dennison beats Q1 earnings estimates with $2.47 EPS amid mixed analyst outlook.

Avery Dennison beats Q1 earnings estimates with $2.47 EPS amid mixed analyst outlook.

Avery Dennison reported strong first-quarter 2026 earnings, surpassing analyst expectations with an adjusted EPS of $2.47. Growth was driven by its Materials Group and Intelligent Labels segments, despite challenges from macroeconomic uncertainty and...

Company Fundamentals
Bullish
52 minutes ago
banner-footerbanner-footer

Invest & Trade with
#1 Award-Winning Investment Super App